Evidence map›Paper›PMID 31973769›Full record

ArticleActa neuropathologica communications2020

N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain.

Amin Mottahedin, Sandrine Blondel, Joakim Ek, Anna-Lena Leverin, Pernilla Svedin, Henrik Hagberg, Carina Mallard, Jean-Francois Ghersi-Egea, Nathalie Strazielle

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Choroid Plexus: The Orchestrator of Long-Range Signalling Within the CNS.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Amin MottahedinFluid Team, Lyon Neurosciences Research Center, INSERM U1028, CNRS UMR5292, University Claude Bernard Lyon-1, Lyon, France.
Sandrine BlondelBlood-Brain Interfaces Exploratory Platform BIP, Lyon Neurosciences Research Center, Lyon, France.
Joakim EkDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Anna-Lena LeverinDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pernilla SvedinDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Henrik HagbergCentre for the Developing Brain, Division of Imaging Sciences and Biomedical Engineering, King's College London, King's Health Partners, St. Thomas' Hospital, London, UK.
Carina MallardDepartment of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Jean-Francois Ghersi-EgeaFluid Team, Lyon Neurosciences Research Center, INSERM U1028, CNRS UMR5292, University Claude Bernard Lyon-1, Lyon, France.
Nathalie StrazielleFluid Team, Lyon Neurosciences Research Center, INSERM U1028, CNRS UMR5292, University Claude Bernard Lyon-1, Lyon, France. ns.brain.i@gmail.com.ORCID 0000-0002-9579-4805
University of Gothenburg · SEUniversité Claude Bernard Lyon 1 · FRCentre de Recherche en Neurosciences de Lyon · FRSt Thomas' Hospital · GB

Funding

SENSITIVE AND SELECTIVE DETECTION OF PEPTIDESR01GM044842 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEBER, STEPHEN G. · 1991 to 2018
$4.9M
Agence Nationale de la Recherche ANR-10-IBHU-003ALF-agreement 722491Cerebral Palsy Alliance Research Foundation PG4416Fondation Leducq DSRR_P34404NIGMS NIH HHS R01 GM044842Swedish Brain Foundation FO2013–095Swedish Brain Foundation FO2014–008Swedish Research Council 2012-2992;2017-01409Torsten Söderberg Foundation M98/15
6 · The paper itself

Abstract

The etiology of neurological impairments associated with prematurity and other perinatal complications often involves an infectious or pro-inflammatory component. The use of antioxidant molecules have proved useful to protect the neonatal brain from injury. The choroid plexuses-CSF system shapes the central nervous system response to inflammation at the adult stage, but little is known on the neuroimmune interactions that take place at the choroidal blood-CSF barrier during development. We previously described that peripheral administration to neonatal mice of the TLR2 ligand PAM3CSK4 (P3C), a prototypic Gram-positive bacterial lipopeptide, induces the migration of innate immune cells to the CSF. Here we showed in neonatal rats exposed to P3C that the migration of neutrophils into the CSF, which occurred through the choroid plexuses, is abolished following administration of the antioxidant drug N-acetylcysteine. Combining light sheet microscopy imaging of choroid plexus, a differentiated model of the blood-CSF barrier, and multiplex cytokine assays, we showed that the choroidal epithelium responds to the bacterial insult by a specific pattern of cytokine secretion, leading to a selective accumulation of neutrophils in the choroid plexus and to their trafficking into CSF. N-acetylcysteine acted by blocking neutrophil migration across both the endothelium of choroidal stromal vessels and the epithelium forming the blood-CSF barrier, without interfering with neutrophil blood count, neutrophil tropism for choroid plexus, and choroidal chemokine-driven chemotaxis. N-acetylcysteine reduced the injury induced by hypoxia-ischemia in P3C-sensitized neonatal rats. Overall, the data show that a double endothelial and epithelial check point controls the transchoroidal migration of neutrophils into the developing brain. They also point to the efficacy of N-acetylcysteine in reducing the deleterious effects of inflammation-associated perinatal injuries by a previously undescribed mechanism, i.e. the inhibition of innate immune cell migration across the choroid plexuses, without interfering with the systemic inflammatory response to infection.

Indexed as

AcetylcysteineAnimalsAntioxidantsBrainCell MovementCells, CulturedCerebrospinal FluidChoroid PlexusFemaleInflammation MediatorsLeukocytesLipopeptidesNeutrophilsRats, Sprague-DawleyRats, WistarAcetylcysteineAntioxidantsInflammation MediatorsLipopeptidesPam(3)CSK(4) peptideBlood-brain barriersInnate immune systemNeuroinflammationNeuroprotectionPerinatal injuryToll-like receptor

Identifiers

PMID31973769
PMCPMC6979079
OpenAlexW3003182595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.